Drawing for NAVIGO

USPTO serial 79219910

NAVIGO

Reviewed by CopyMark Law Group

Reg. 5645889Status 706Registered
Filing date
Status date
Registration date
Jan 8, 2019
Examiner
RHIM, ANDREW
Law office
Historical data usage

What this means

This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.

Need help with NAVIGO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Adam D. Mandell

Adam D. Mandell Millen, White, Zelano & Branigan, P.C.2200 Clarendon Blvd., Ste 1400Arlington, VA 22201United States

Goods and services

ClassDescriptionStatusFirst use
001Chemical, biological, analytical, and/or chromatographic substances, active agents, and/or compositions, namely, polypeptides, proteins or peptides in raw form for scientific research, namely, for analysis of polypeptide, protein and peptide interaction, all of the foregoing not for medical or veterinary useACTIVE
005Diagnostic, therapeutic, analytical, biological, chemical, biochemical substances, active agents, and/or compositions, namely, diagnostic preparations for medical [ and veterinary ] use, therapeutic preparations for medical [ and veterinary use, namely, medicated bath preparations, ] pharmaceutical preparations for the medical treatment of cancer, metabolic, inflammatory, skin, eye and cardiovascular diseases, and chemical reagents for medical or veterinary purposesACTIVE
042Scientific and technological services, namely, scientific research and analysis in the fields of pharmaceutical, diagnostic, analytical or biochemical substances; scientific and technological services, namely, scientific research in the fields of the identification, further development, and use of biochemical, pharmaceutical, analytical and diagnostic products; scientific laboratory services in the fields of molecular biological, biotechnological, biochemical or pharmaceutical products; research and development in the field of medical and veterinary diagnostics and treatment using molecular biological, genetic engineering, biotechnological or biochemical methods, and in the field of identification, screening and development of pharmaceutically active components, and test methods and test kitsACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 13, 2026INNPPARTIAL INVALIDATION PROCESSED BY THE IB
Jul 22, 2026INPSPARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Jul 21, 2026INPCINVALIDATION PROCESSED
Dec 28, 2025INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Apr 28, 2025NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Apr 28, 202571AGREGISTERED-SEC.71 ACCEPTED
Apr 28, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL
Dec 18, 2024ES71TEAS SECTION 71 RECEIVED
Jan 8, 2024REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
May 3, 2019FINOFINAL DECISION TRANSACTION PROCESSED BY IB
Apr 11, 2019FICSFINAL DISPOSITION NOTICE SENT TO IB
Apr 11, 2019FIMPFINAL DISPOSITION PROCESSED
Apr 8, 2019FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jan 8, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 23, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 23, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 19, 2018GPNXNOTIFICATION PROCESSED BY IB
Oct 3, 2018OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Oct 3, 2018OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Oct 3, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 13, 2018PBERWITHDRAWN FROM PUB - EXAMINING ATTORNEY REQUEST
Aug 31, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Aug 31, 2018XAECEXAMINER'S AMENDMENT ENTERED
Aug 31, 2018GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 31, 2018GNEAEXAMINERS AMENDMENT E-MAILED
Aug 31, 2018CNEAEXAMINERS AMENDMENT -WRITTEN
Jun 12, 2018GNFNNOTIFICATION OF FINAL REFUSAL EMAILED
Jun 12, 2018GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jun 12, 2018CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
May 24, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED
May 24, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
May 24, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 17, 2017RFNTREFUSAL PROCESSED BY IB
Nov 30, 2017RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 30, 2017RFRRREFUSAL PROCESSED BY MPU
Nov 17, 2017RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 16, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 16, 2017DOCKASSIGNED TO EXAMINER
Nov 10, 2017MAFRAPPLICATION FILING RECEIPT MAILED
Nov 6, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 2, 2017REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance